Abstract
Recently, a new generation of highly promising inhibitors bearing β-keto-enol functionality has emerged. Reported herein is the first synthesis and use of novel designed drugs based on the β-keto-enol group embedded with heterocyclic moieties such as pyrazole, pyridine, and furan, prepared in a one-step procedure by mixed Claisen condensation. All the newly synthesized compounds were characterized by FT-IR, 1H-NMR, 13C-NMR, ESI/LC-MS, elemental analysis, and evaluated for their in vitro antiproliferative activity against breast cancer (MDA-MB241) human cell lines and fungal strains (Fusarium oxysporum f.sp albedinis FAO). Three of the synthesized compounds showed potent activity against fungal strains with IC50 values in the range of 0.055-0.092 μM. The results revealed that these compounds showed better IC50 values while compared with positive controls.
Author supplied keywords
Cite
CITATION STYLE
Radi, S., Tighadouini, S., Feron, O., Riant, O., Bouakka, M., Benabbes, R., & Mabkhot, Y. N. (2015). Synthesis of novel β-keto-enol derivatives tethered pyrazole, pyridine and furan as new potential antifungal and anti-breast cancer agents. Molecules, 20(11), 20186–20194. https://doi.org/10.3390/molecules201119684
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.